1. Home
  2. PHIN vs QURE Comparison

PHIN vs QURE Comparison

Compare PHIN & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PHINIA Inc.

PHIN

PHINIA Inc.

HOLD

Current Price

$71.59

Market Cap

2.7B

Sector

N/A

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

N/A

Current Price

$48.08

Market Cap

3.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PHIN
QURE
Founded
2023
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.2B
IPO Year
2023
2013

Fundamental Metrics

Financial Performance
Metric
PHIN
QURE
Price
$71.59
$48.08
Analyst Decision
Buy
Buy
Analyst Count
5
14
Target Price
$70.00
$45.00
AVG Volume (30 Days)
359.6K
1.3M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
1.66%
N/A
EPS Growth
84.09
29.67
EPS
2.01
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
$6.35
$126.12
Revenue Next Year
$2.29
$200.43
P/E Ratio
$36.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$50.80
$8.73
52 Week High
$86.94
$71.50

Technical Indicators

Market Signals
Indicator
PHIN
QURE
Relative Strength Index (RSI) 39.12 62.59
Support Level $70.54 $39.50
Resistance Level $74.68 $50.47
Average True Range (ATR) 2.03 1.93
MACD -0.25 0.22
Stochastic Oscillator 0.00 82.41

Price Performance

Historical Comparison
PHIN
QURE

About PHIN PHINIA Inc.

Phinia Inc is engaged in the development, design, and manufacture of integrated components and systems that optimize performance, increase efficiency, and reduce emissions in combustion and hybrid propulsion for commercial vehicles, industrial applications, and light vehicles. Its product portfolio includes alternative fuel systems, fuel delivery modules, evaporative canisters, diesel fuel injection systems, electrical systems, hydrogen solutions, associated software, and others. The company's reportable segments are; the Fuel Systems segment, which derives key revenue, and the Aftermarket segment. Geographically, it generates maximum revenue from the United States and the rest from the United Kingdom, China, Poland, Romania, Brazil, and other regions.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: